Company Overview and News

 
Jumbo to continue facing near-term cost pressures with ongoing expansion: DBS

2018-08-14 theedgemarkets
SINGAPORE (Aug 14): DBS Group Research is maintaining “Hold” on Jumbo Group with a lower target price of 57 Singaporean cents, based on 23 times FY19F earnings.
42R

8
Walmart Bests Whole Foods in Study of Food Supply's Human Toll - Bloomberg

2018-06-21 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
TESO WFM KR TSCDY TSCDF 42R TSCO

10
The Singapore stocks to watch during the Trump-Kim summit

2018-06-10 scmp
There’s more than one way to play the Trump-Kim summit in the world of stocks. Apart from the obvious North Asian and US equities, there’s another geography investors can consider: Singapore – and its consumer stocks, to be precise.
S07 C6L SK7 CDGLF BTKGF 5DA ACTRF SHALF SINGY Q5T O39 GIGNY 42R A68U G13 0069 CDGLY H15 A34 GIGNF FHOSY J85 SHALY SINGF

 
Hong Kong's Tsui Wah to open first Singapore outlet in Clarke Quay on Jun 15

2018-05-30 channelnewsasia
SINGAPORE: Hong Kong's famous Tsui Wah eatery will open its first Singapore outlet at Clarke Quay on Jun 15, the chain announced on Wednesday (May 30).
42R

 
Tsui Wah Singapore to open Clarke Quay outlet on Jun 15

2018-05-30 channelnewsasia
SINGAPORE: Hong Kong's famous Tsui Wah eatery will open its first Singapore outlet at Clarke Quay on Jun 15, the chain announced on Wednesday (May 30).
42R

 
Gaming industry still a safe bet in PH amid changing rules, rising competition

2018-05-28 business.inquirer.net
In a country which is 80 percent Catholic, it would seem surprising that the gaming industry has taken off: the Philippines has become one of the key markets for casinos in Asia after Macau and Singapore.
0027 BBRRF BLOOM GXYEF GXYYY 42R

 
Hong Kong's Tsui Wah to open first Singapore outlet at Clarke Quay - Channel NewsAsia

2018-03-15 channelnewsasia
SINGAPORE: Hong Kong's famous Tsui Wah eatery will open its first Singapore outlet at Clarke Quay, the chain told Channel NewsAsia on Thursday (Mar 15).
42R

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...